Abstract
The present study has examined several characteristics of the release of 5‐HT in the median raphe nucleus in terms of its dependence of nerve impulse, provenance of a vesicular storage fraction as well as the regulatory role played by 5‐HT1A receptors. Tetrodotoxin (1 μm) and reserpine (5 mg kg−1, i.p.) virtually suppressed the output of 5‐HT. The administration of EEDQ (10 mg kg−1, i.p.) did not alter the basal release of 5‐HT but abolished the reduction of 5‐HT release induced by 8‐OH‐DPAT (0.1 mg kg−1, s.c.). The perfusion of 1–100 μm of 8‐OH‐DPAT or the novel 5‐HT1A agonist BAY×3702 decreased the efflux of 5‐HT, whereas the perfusion of the 5‐HT1A antagonist WAY‐100635 failed to alter 5‐HT release. The decrease in dialysate 5‐HT induced by 100 μm 8‐OH‐DPAT was reversed by the concurrent perfusion of 100 μm WAY‐100635. Also, the perfusion of 100 μm WAY‐100635 for 2 h inhibited partly the reduction of 5‐HT release evoked by the systemic administration of 8‐OH‐DPAT (0.1 mg kg−1). These results indicate that extracellular 5‐HT in the median raphe nucleus is stored in vesicles and released in an impulse‐dependent manner. Also, the basal release of 5‐HT in the median raphe nucleus does not appear to be under the tonic control of somatodendritic 5‐HT1A receptors by endogenous 5‐HT. Instead, this feedback mechanism seems to be triggered when an excess of the transmitter or a 5‐HT1A agonist is present in the extracellular space of the median raphe nucleus. British Journal of Pharmacology (1998) 125, 1361–1367; doi:10.1038/sj.bjp.0702206

This publication has 52 references indexed in Scilit: